N-乙酰半胱氨酸对新型冠状病毒肺炎及其后遗症的影响：一项大型队列研究的结果
Impact of -acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study.
作者信息
Faverio Paola, Rebora Paola, Rossi Emanuela, Del Giudice Savino, Montanelli Filippo, Garzillo Laura, Busnelli Sara, Luppi Fabrizio, Valsecchi Maria Grazia, Pesci Alberto
机构信息
School of Medicine and Surgery, University of Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST Monza, Monza, Italy.
Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, University of Milano Bicocca, Monza, Italy.
出版信息
ERJ Open Res. 2021 Feb 7;8(1). doi: 10.1183/23120541.00542-2021. eCollection 2022 Jan.
Abstract
摘要
https://bit.ly/3l1QsVo. （此为网址，直接保留原文形式无法准确翻译为中文，可根据实际用途说明这是一个链接地址）
相似文献
1
Impact of -acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study.
ERJ Open Res. 2021 Feb 7;8(1). doi: 10.1183/23120541.00542-2021. eCollection 2022 Jan.
2
N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.
Infect Dis (Lond). 2021 Nov;53(11):847-854. doi: 10.1080/23744235.2021.1945675. Epub 2021 Jun 29.
3
SARS-CoV-2: minireview and review of first case in Foshan, China.
ERJ Open Res. 2020 Jun 22;6(2). doi: 10.1183/23120541.00090-2020. eCollection 2020 Apr.
4
Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?
Chest. 1998 Jun;113(6):1616-24. doi: 10.1378/chest.113.6.1616.
5
Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort.
Crit Care. 2021 May 25;25(1):177. doi: 10.1186/s13054-021-03588-4.
6
Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial.
Med Gas Res. 2018 Apr 18;8(1):19-23. doi: 10.4103/2045-9912.229599. eCollection 2018 Jan-Mar.
7
Getting a Knack for NAC: N-Acetyl-Cysteine.
Innov Clin Neurosci. 2011 Jan;8(1):10-4.
8
Formation of three N-acetyl-L-cysteine monoadducts and one diadduct by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with N-acetyl-L-cysteine at physiological conditions: chemical mechanisms and toxicological implications.
Chem Res Toxicol. 2007 Oct;20(10):1563-9. doi: 10.1021/tx700263w. Epub 2007 Sep 25.
9
Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study.
PLoS One. 2013;8(1):e54163. doi: 10.1371/journal.pone.0054163. Epub 2013 Jan 23.
10
Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort.
ERJ Open Res. 2021 Nov 1;7(4). doi: 10.1183/23120541.00384-2021. eCollection 2021 Oct.
引用本文的文献
1
N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations.
Int J Mol Sci. 2025 Mar 15;26(6):2657. doi: 10.3390/ijms26062657.
2
Real-World Patients' Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey.
Infect Dis Ther. 2024 Aug;13(8):1907-1920. doi: 10.1007/s40121-024-01015-z. Epub 2024 Jul 10.
3
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.
NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2.
4
Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern.
J Mol Cell Biol. 2024 Aug 26;16(3). doi: 10.1093/jmcb/mjae004.
5
Pharmacogenomic Landscape of Ivermectin and Selective Antioxidants: Exploring Gene Interplay in the Context of Long COVID.
Int J Mol Sci. 2023 Oct 23;24(20):15471. doi: 10.3390/ijms242015471.
6
N-acetylcysteine reduces severity and mortality in COVID-19 patients: A systematic review and meta-analysis.
J Adv Vet Anim Res. 2023 Jun 30;10(2):157-168. doi: 10.5455/javar.2023.j665. eCollection 2023 Jun.
7
Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expression.
Sci Rep. 2023 May 16;13(1):7894. doi: 10.1038/s41598-023-34785-6.
8
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions.
J Infect Public Health. 2022 Dec;15(12):1477-1483. doi: 10.1016/j.jiph.2022.11.009. Epub 2022 Nov 12.
本文引用的文献
1
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study.
Respiration. 2021;100(11):1078-1087. doi: 10.1159/000518141. Epub 2021 Aug 19.
2
A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
Pharmacol Rep. 2021 Dec;73(6):1650-1659. doi: 10.1007/s43440-021-00296-2. Epub 2021 Jun 10.
3
N-Acetylcysteine to Combat COVID-19: An Evidence Review.
Ther Clin Risk Manag. 2020 Nov 2;16:1047-1055. doi: 10.2147/TCRM.S273700. eCollection 2020.
4
Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis. 2021 Jun 1;72(11):e736-e741. doi: 10.1093/cid/ciaa1443.
5
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
J Gen Intern Med. 2020 Nov;35(11):3308-3314. doi: 10.1007/s11606-020-06146-w. Epub 2020 Sep 3.
6
Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.
FASEB J. 2020 Oct;34(10):13185-13193. doi: 10.1096/fj.202001807. Epub 2020 Aug 11.
7
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Clin Immunol. 2020 Oct;219:108544. doi: 10.1016/j.clim.2020.108544. Epub 2020 Jul 22.
8
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
9
The cytokine storm and COVID-19.
J Med Virol. 2021 Jan;93(1):250-256. doi: 10.1002/jmv.26232. Epub 2020 Sep 30.
Zotero 插件